Literature DB >> 15383554

Receptor editing in positive and negative selection of B lymphopoiesis.

Efrat Edry1, Doron Melamed.   

Abstract

In B lymphopoiesis, Ag receptor expression and signaling are critical to determine developmental progression, survival, and activation. Several positive and negative selection checkpoints to test this receptor have been described in B lymphopoiesis, aiming to ensure the generation of functionally competent, nonautoimmune repertoire. Secondary Ag receptor gene recombination allows B lymphocytes to replace an inappropriate receptor with a new receptor, a mechanism called receptor editing. This salvage mechanism uncouples the Ag receptor fate from that of the cell itself, suggesting that B cell repertoire is regulated by a process of receptor selection. Secondary rearrangements are stimulated in different stages of B cell development, where editing of the receptor is necessary to fulfill stage-specific requirements. In this study, we discuss the contribution of receptor editing in B lymphopoiesis and its regulation by positive and negative selection signals.

Mesh:

Substances:

Year:  2004        PMID: 15383554     DOI: 10.4049/jimmunol.173.7.4265

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.

Authors:  Xueling Wu; Tongqing Zhou; Jiang Zhu; Baoshan Zhang; Ivelin Georgiev; Charlene Wang; Xuejun Chen; Nancy S Longo; Mark Louder; Krisha McKee; Sijy O'Dell; Stephen Perfetto; Stephen D Schmidt; Wei Shi; Lan Wu; Yongping Yang; Zhi-Yong Yang; Zhongjia Yang; Zhenhai Zhang; Mattia Bonsignori; John A Crump; Saidi H Kapiga; Noel E Sam; Barton F Haynes; Melissa Simek; Dennis R Burton; Wayne C Koff; Nicole A Doria-Rose; Mark Connors; James C Mullikin; Gary J Nabel; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola
Journal:  Science       Date:  2011-08-11       Impact factor: 47.728

Review 2.  Aging and neoteny in the B lineage.

Authors:  Doron Melamed; David W Scott
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

3.  YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus.

Authors:  Xuan Pan; Madhusudhan Papasani; Yi Hao; Marco Calamito; Fang Wei; William J Quinn Iii; Arindam Basu; Junwen Wang; Suchita Hodawadekar; Kristina Zaprazna; Huifei Liu; Yang Shi; David Allman; Michael Cancro; Michael L Atchison
Journal:  EMBO J       Date:  2013-03-26       Impact factor: 11.598

Review 4.  Primary immunoglobulin repertoire development: time and space matter.

Authors:  Alessandra Granato; Yuezhou Chen; Duane R Wesemann
Journal:  Curr Opin Immunol       Date:  2015-03-19       Impact factor: 7.486

5.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

6.  Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing.

Authors:  Li Bai; Yuhong Chen; Yinghong He; Xuezhi Dai; Xueyan Lin; Renren Wen; Demin Wang
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

7.  Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.

Authors:  Mei Yu; Yuhong Chen; Yinghong He; Andrew Podd; Guoping Fu; Jacqueline A Wright; Eden Kleiman; Wasif N Khan; Renren Wen; Demin Wang
Journal:  J Immunol       Date:  2012-10-19       Impact factor: 5.422

8.  Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.

Authors:  Sophie Hillion; Soizic Garaud; Valérie Devauchelle; Anne Bordron; Christian Berthou; Pierre Youinou; Christophe Jamin
Journal:  Immunology       Date:  2007-07-03       Impact factor: 7.397

9.  Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy.

Authors:  Ida Franiak-Pietryga; Sayuri Miyauchi; Sangwoo Shawn Kim; Philip Dominick Sanders; Whitney Sumner; Lin Zhang; A J Mundt; Joseph A Califano; Andrew B Sharabi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-30       Impact factor: 8.013

10.  Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1.

Authors:  Alexander Karnowski; Chun Cao; Gabriele Matthias; Sebastian Carotta; Lynn M Corcoran; Inga-Lill Martensson; Jane A Skok; Patrick Matthias
Journal:  PLoS One       Date:  2008-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.